Tofacitinib Therapeutic Cheat Sheet
Welcome to our new series, Therapeutic Cheat Sheet, wherein we take a deep dive into the literature and guidelines to give you a quick reference on the use of new or complex therapies. This series will become your go-to for information about dosing, potential interactions and laboratory monitoring, just to name a few. First up: Tofacitinib.
[caption id="attachment_6617" align="aligncenter" …
Welcome to our new series, Therapeutic Cheat Sheet, wherein we take a deep dive into the literature and guidelines to give you a quick reference on the use of new or complex therapies. This series will become your go-to for information about dosing, potential interactions and laboratory monitoring, just to name a few. First up: Tofacitinib.
[caption id="attachment_6617" align="aligncenter" … 
In this month’s installment of our Therapeutic Cheat Sheet Series, we turn our focus to rosacea. Antibiotics have been a mainstay for rosacea treatment for decades, but their side effect profile and dosing schedules can complicate their use. Enter Doxycycline-Modified Release (Doxy-MR). This specialized formulation of doxycycline allows for sustained activity and a minimized side effect prof … 
In the newest installment of our Therapeutic Cheat Sheet series, we turn to the treatment of acne. Mutli-mechanistic approaches result in improved outcomes for patients, especially when it comes to the multifactorial causes of acne. Adapalene 0.3%-benzoyl peroxide 2.5% gel (also known as Epiduo Forte) provides a useful tool for delivering two mainstays of acne therapy in one topical agent.
[ … 
Dermatology practices often deal with denials and even audits because the complexities of billing and coding lend themselves to a lot of billing and coding errors. Billing and coding for dermatology requires detailed reporting, detailed information on procedures completed and following multiple procedure rules. Throughout the past several years, multiple changes have been made to dermatology codes … 
Media attention about oral minoxidil has impacted access to the hair loss drug in the Washington, D.C. area, according to a study published in the January issue of the Journal of Drugs in Dermatology. Researchers found shortages of the drug in D.C.-area pharmacies more than a year after an article about the treatment appeared in The New York Times.
To find out more about oral minoxidil access, … 